Results 51 to 60 of about 5,506,892 (338)

MATHEMATICAL MODEL FOR CALCULATION OF INFORMATION RISKS FOR INFORMATION AND LOGISTICS SYSTEM [PDF]

open access: yesНаучно-технический вестник информационных технологий, механики и оптики, 2015
Subject of research. The paper deals with mathematical model for assessment calculation of information risks arising during transporting and distribution of material resources in the conditions of uncertainty. Meanwhile information risks imply the danger
A. G. Korobeynikov   +5 more
doaj   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Resources for Information Literacy Instruction in the Sciences.

open access: yesIssues in Science and Technology Librarianship, 2008
This bibliography contains a collection of web sites and online resources that pertain to information literacy sources for scientific disciplines. This web bibliography, or "webliography", contains links and descriptions of web sites that cover general ...
Maribeth Slebodnik   +1 more
doaj   +1 more source

Q & A on Customized Employment: Assistive Technology as a Workplace Support [PDF]

open access: yes, 2005
[Excerpt] Despite the promise of assistive technology, many people with significant physical disabilities remain in facility-based employment programs. Underutilization of AT to facilitate competitive employment is related to a number of critical issues.
Office of Disability Employment Policy
core   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Computerized Management Information Systems Resources and their Relationship to the Development of Performance in the Electricity Distribution Company in Gaza [PDF]

open access: yes, 2016
This paper aims to identify computerized management information systems resources and their relationship to the development of performance in the Electricity Distribution Company in Gaza. This research used two dimensions.
Abu Naser, Samy S., Al Shobaki, Mazen J.
core  

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Resource Allocation with Population Dynamics

open access: yes, 2016
Many analyses of resource-allocation problems employ simplistic models of the population. Using the example of a resource-allocation problem of Marecek et al.
Epperlein, Jonathan, Marecek, Jakub
core   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy